Gökhan Uçar

477 total citations
42 papers, 254 citations indexed

About

Gökhan Uçar is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Gökhan Uçar has authored 42 papers receiving a total of 254 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 20 papers in Pulmonary and Respiratory Medicine and 10 papers in Surgery. Recurrent topics in Gökhan Uçar's work include Renal cell carcinoma treatment (9 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Colorectal Cancer Treatments and Studies (6 papers). Gökhan Uçar is often cited by papers focused on Renal cell carcinoma treatment (9 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Colorectal Cancer Treatments and Studies (6 papers). Gökhan Uçar collaborates with scholars based in Türkiye, United Kingdom and United States. Gökhan Uçar's co-authors include Yakup Ergün, Baran Akagündüz, Mustafa Seçil, Doğan Uncu, Oğuz Dıcle, Öznur Bal, Nuriye Özdemir, Mehmet Alı Nahıt Şendur, Ozan Yazıcı and Cengiz Karaçin and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Medicine.

In The Last Decade

Gökhan Uçar

34 papers receiving 252 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gökhan Uçar Türkiye 11 136 83 55 44 35 42 254
Giovanni Maria Iannantuono Italy 9 69 0.5× 76 0.9× 32 0.6× 50 1.1× 39 1.1× 23 237
Vinay Mathew Thomas United States 10 76 0.6× 124 1.5× 50 0.9× 46 1.0× 41 1.2× 52 312
Geòrgia Anguera Spain 11 136 1.0× 116 1.4× 48 0.9× 37 0.8× 12 0.3× 43 281
Raghu Rajan Canada 10 94 0.7× 104 1.3× 42 0.8× 101 2.3× 24 0.7× 21 375
Denise Sheehan United Kingdom 5 51 0.4× 111 1.3× 45 0.8× 144 3.3× 29 0.8× 9 261
Sjaak Burgers Netherlands 11 158 1.2× 336 4.0× 33 0.6× 22 0.5× 36 1.0× 21 456
Robin Schaffar Switzerland 10 196 1.4× 126 1.5× 64 1.2× 33 0.8× 27 0.8× 19 338
Crystal J. Hessman United States 6 107 0.8× 55 0.7× 70 1.3× 72 1.6× 20 0.6× 6 233
Felicia Roncolato Australia 8 133 1.0× 55 0.7× 41 0.7× 43 1.0× 15 0.4× 31 247
Yibo Wang China 11 145 1.1× 77 0.9× 57 1.0× 55 1.3× 20 0.6× 18 340

Countries citing papers authored by Gökhan Uçar

Since Specialization
Citations

This map shows the geographic impact of Gökhan Uçar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gökhan Uçar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gökhan Uçar more than expected).

Fields of papers citing papers by Gökhan Uçar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gökhan Uçar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gökhan Uçar. The network helps show where Gökhan Uçar may publish in the future.

Co-authorship network of co-authors of Gökhan Uçar

This figure shows the co-authorship network connecting the top 25 collaborators of Gökhan Uçar. A scholar is included among the top collaborators of Gökhan Uçar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gökhan Uçar. Gökhan Uçar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Cömert, Günsu Kimyon, et al.. (2024). Does neoadjuvant chemotherapy reduce surgical complexity in patients with advanced-stage epithelial ovarian cancer?. BMC Women s Health. 24(1). 435–435.
3.
Akyürek, Nalân, Gökhan Uçar, Doğan Uncu, et al.. (2024). Retrospective Analyses of PD-L1, LAG-3, TIM-3, OX40L Expressions and MSI Status in Gastroenteropancreatic Neuroendocrine Neoplasms. Cancer Investigation. 42(2). 141–154.
4.
5.
Kuzu, Omer F., Deniz Tural, Sung Hoon Sim, et al.. (2024). Treatment Patterns and Attrition in Metastatic Renal Cell Carcinoma: Real-Life Experience from the Turkish Oncology Group Kidney Cancer Consortium (TKCC) Database. Clinical Genitourinary Cancer. 23(1). 102282–102282. 1 indexed citations
6.
Uçar, Gökhan, et al.. (2024). Clinical features and prognostic factors in thymoma and thymic carcinoma. Indian Journal of Thoracic and Cardiovascular Surgery. 40(6). 660–668.
7.
Uçar, Gökhan, et al.. (2023). Cabozantinib-induced heart failure. Journal of Oncology Pharmacy Practice. 30(1). 225–227. 1 indexed citations
8.
Ergün, Yakup, Gökhan Uçar, & Baran Akagündüz. (2023). Comparison of HER2-zero and HER2-low in terms of clinicopathological factors and survival in early-stage breast cancer: A systematic review and meta-analysis. Cancer Treatment Reviews. 115. 102538–102538. 35 indexed citations
9.
10.
11.
12.
Yekedüz, Emre, Deniz Tural, Özlem Erçelep, et al.. (2022). The relationship between systemic immune inflammation index and survival in patients with metastatic renal cell carcinomatreated withtyrosine kinase inhibitors. Scientific Reports. 12(1). 16559–16559. 10 indexed citations
13.
Yekedüz, Emre, Deniz Tural, Nuri Karadurmuş, et al.. (2021). Nivolumab as second-line treatment and beyond for metastatic renal cell carcinoma: A real-life experience from Turkish Oncology Group Kidney Cancer Consortium (TKCC) Database.. Journal of Clinical Oncology. 39(6_suppl). 321–321. 1 indexed citations
14.
Uçar, Gökhan, Yakup Ergün, Öznur Bal, et al.. (2020). Sunitinib or Pazopanib: Is There Any Difference Between Tyrosine Kinase Inhibitors in the Pre-Nivolumab Setting in Metastatic Renal Cell Carcinoma?. Cureus. 12(9). e10525–e10525. 5 indexed citations
15.
Akyürek, Nalân, Olçay Kandemir, Ayşe Ocak Duran, et al.. (2020). PD-L1 expression in immune cells is a favorable prognostic factor for nasopharyngeal carcinoma. Indian Journal of Cancer. 58(4). 561–561. 2 indexed citations
16.
Uçar, Gökhan, et al.. (2020). Prognostic and Predictive Value of NAR Score in Gastric Cancer. Journal of Gastrointestinal Cancer. 52(3). 1054–1060. 1 indexed citations
17.
Uçar, Gökhan, et al.. (2020). The effect of chemotherapy on olfactory function and mucociliary clearance. Supportive Care in Cancer. 29(3). 1635–1641. 4 indexed citations
18.
Ergün, Yakup, et al.. (2020). Does primary tumor resection contribute to overall survival in unresectable synchronous metastatic colorectal cancer?. Journal of Research in Medical Sciences. 25(1). 14–14. 12 indexed citations
19.
Uçar, Gökhan, Mustafa Seçil, Ömer Demir, et al.. (2007). The combined use of brachial artery flow-mediated dilatation and carotid artery intima-media thickness measurements may be a method to determine vasculogenic erectile dysfunction. International Journal of Impotence Research. 19(6). 577–583. 15 indexed citations
20.
Seçil, Mustafa & Gökhan Uçar. (2004). Spontaneous duodenal hematoma. Journal of Emergency Medicine. 27(3). 291–293. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giovanni Maria Iannantuono Breakdown of academic impact, for papers by Vinay Mathew Thomas Breakdown of academic impact, for papers by Geòrgia Anguera Breakdown of academic impact, for papers by Raghu Rajan Breakdown of academic impact, for papers by Denise Sheehan Breakdown of academic impact, for papers by Sjaak Burgers Breakdown of academic impact, for papers by Robin Schaffar Breakdown of academic impact, for papers by Crystal J. Hessman Breakdown of academic impact, for papers by Felicia Roncolato Breakdown of academic impact, for papers by Yibo Wang
Rankless by CCL
2026